How long till semaglutide works — and what to expect week by week

Semaglutide (Wegovy) is active in the body from the first dose, but appetite-reducing effects and weight changes accumulate over weeks, not days.
The titration ladder (starting at 0.25 mg and stepping up roughly every four weeks) means the medicine's full impact unfolds gradually by design.
In the STEP 1 clinical trial, participants on 2.4 mg semaglutide lost an average of around 15% of body weight over 68 weeks, published in the New England Journal of Medicine.
Individual results vary with starting weight, diet, activity and how well the dose is tolerated, the pattern over months matters more than any single week's reading.

Semaglutide starts acting in your body within hours of the first injection, but noticeable weight loss typically takes four to eight weeks, with most people seeing meaningful change by weeks twelve to sixteen. That timeline is shaped by the titration schedule: doses rise gradually, and the full effect builds as your body adjusts. These are prescription-only medicines, so a prescriber determines whether they are clinically suitable for you — and what realistic progress looks like at each stage.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The honest week-by-week picture: what semaglutide is actually doing at each stage

Week one: the medicine is working, even when the scales aren't

Picture this: you've done your first injection, you've put the pen back in the fridge, and by the following morning you're wondering why you don't feel dramatically different. That's completely normal, and it's a question our prescribers hear regularly. The 0.25 mg starting dose is deliberately low. Its job is to let your digestive system adapt to the medicine, not to deliver the headline result, nausea and gut discomfort are far more likely at a full therapeutic dose taken from day one, which is why the schedule exists.

What is happening under the surface: semaglutide binds to GLP-1 receptors in the gut and brain, slowing how quickly your stomach empties and signalling satiety to the hypothalamus. Blood levels of the drug reach a steady state after about a week of weekly injections. If you're curious about how long before semaglutide works in a physiological sense, the honest answer is that meaningful receptor activity begins far sooner than most people expect, which is why so many notice feeling full faster at meals, or that cravings are quieter, by the end of week one or two. The scales may not have moved yet. That isn't failure.

You can read more about what to expect across the full Wegovy journey on our Wegovy treatment page.

Weeks four to twelve: where the real change usually begins

This is the window most people look back on as the turning point. By week four, the dose typically steps up to 0.5 mg; by week eight, to 1.0 mg. Each increase brings a stronger appetite signal and, usually, a clearer pattern of weight loss. Research on how long Wegovy takes to produce results consistently shows that the four-to-twelve-week period is when the majority of people start recording weekly losses of around 0.5–1 kg, though this varies considerably.

What helps most at this stage: eating enough protein to protect muscle as weight comes off, keeping hydrated, and not skipping doses. If side effects like nausea are significant, that's a conversation for your prescriber, slowing the titration is sometimes the right call, and it doesn't mean the medicine isn't working. For a closer look at how fast semaglutide works during this titration phase, our dedicated page breaks down what the clinical evidence shows week by week. Worth knowing: gastrointestinal symptoms tend to be worst at the point of a dose increase, then settle.

The NHS medicines page for semaglutide provides a plain-language overview of what to expect, including when to seek advice.

Months three to six and beyond: when the cumulative effect compounds

By the time the 1.7 mg and then 2.4 mg maintenance doses are reached (usually around months three to five) semaglutide's appetite-suppressing effect is at its strongest. This is where trial data becomes relevant context: in STEP 1, the 15% average weight loss figure was reached over 68 weeks, not six. The curve isn't a straight line; it tends to be steeper in months two through six, then flatter as the body finds a new equilibrium. Some people lose significant weight in the first three months; others see the same total loss spread more evenly.

A detail that surprises people: weight loss can continue for months even after the dose stabilises, as the body adapts. Plateaus are common and almost always temporary. If you're curious whether first-month progress predicts longer-term results, we've looked at the evidence around what happens in the first month of Wegovy. The honest answer is that early progress is encouraging but not definitive, the months that follow matter just as much.

If you're weighing up treatment options or want to understand costs before speaking to a prescriber, our weight-loss treatments page sets out what's included and how the process works.

Why timelines differ from person to person

Two people can take exactly the same dose on the same schedule and lose weight at noticeably different rates. Starting BMI plays a role: a higher starting weight often means larger absolute losses in the early months, even if the percentage is similar. Metabolic factors, sleep quality, stress hormones and how much lean muscle mass is preserved through activity all feed into the outcome. And adherence to the titration schedule matters, dose increases skipped or delayed mean the timeline shifts accordingly.

Age and background medical history can also influence the pace, and understanding how long till semaglutide kicks in for your particular profile is something a prescriber can help you think through, since they consider your full clinical picture rather than BMI alone. This is precisely why semaglutide is a prescription-only medicine rather than something available without clinical oversight. A prescriber can look at your specific picture (not just your BMI) and advise whether the pace of change is what the evidence suggests it should be, or whether something needs adjusting.

If you'd like to speak to one of our GPhC-registered prescribers about your situation, the process starts with a free consultation. Speak to our prescribers through our weight-loss treatments page, consultations are reviewed the same day, by a real clinician.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions